Shu Meng1, Jie Lv2, Palas K Chanda1, Iris Owusu1, Kaifu Chen2, John P Cooke1. 1. Center for Cardiovascular Regeneration (S.M., P.K.C., I.O., J.P.C.), Department of Cardiovascular Sciences, Houston Methodist Research Institute, TX. 2. Center for Bioinformatics and Computational Biology (J.L., K.C.), Department of Cardiovascular Sciences, Houston Methodist Research Institute, TX.
Abstract
BACKGROUND: The angiogenic response to ischemia restores perfusion so as to preserve tissue. A role for mesenchymal-to-endothelial transition in the angiogenic response is controversial. This study is to determine if resident fibroblasts contribute to angiogenesis. METHODS: We utilized the murine model of hindlimb ischemia, and in vivo Matrigel plug assay together with lineage tracing studies and single cell RNA-sequencing to examine the transcriptional and functional changes in fibroblasts in response to ischemia. RESULTS: Lineage tracing using Fsp1-Cre: R26R-EYFP mice revealed the emergence within the ischemic hindlimb of a small subset of YFP+ CD144+ CD11b- fibroblasts (E* cells) that expressed endothelial cell (EC) genes. Subcutaneous administration of Matrigel in Fsp1-Cre: R26R-EYFP mice generated a plug that became vascularized within 5 days. Isolation of YFP+ CD11b- cells from the plug revealed a small subset of YFP+ CD144+ CD11b- E* cells which expressed EC genes. Pharmacological or genetic suppression of innate immune signaling reduced vascularity of the Matrigel plug and abrogated the generation of these E* cells. These studies were repeated using human fibroblasts, with fluorescence-activated cell sorting analysis revealing that a small percentage of human fibroblasts that were induced to express EC markers in Matrigel plug assay. Pharmacological suppression or genetic knockout of inflammatory signaling abolished the generation of E* cells, impaired perfusion recovery and increased tissue injury after femoral artery ligation. To further characterize these E* cells, single cell RNA-sequencing studies were performed and revealed 8 discrete clusters of cells expressing characteristic fibroblast genes, of which 2 clusters (C5 and C8) also expressed some EC genes. Ischemia of the hindlimb induced expansion of clusters C5 and C8. The C8 cells did not express CD144, nor did they form networks in Matrigel, but did generate angiogenic cytokines. The C5 fibroblasts most resembled E* cells in their expression of CD144 and their ability to form EC-like networks in Matrigel. CONCLUSIONS: Together, these studies indicate the presence of subsets of tissue fibroblasts which seem poised to contribute to the angiogenic response. The expansion of these subsets with ischemia is dependent on activation of innate immune signaling and contributes to recovery of perfusion and preservation of ischemic tissue.
BACKGROUND: The angiogenic response to ischemia restores perfusion so as to preserve tissue. A role for mesenchymal-to-endothelial transition in the angiogenic response is controversial. This study is to determine if resident fibroblasts contribute to angiogenesis. METHODS: We utilized the murine model of hindlimb ischemia, and in vivo Matrigel plug assay together with lineage tracing studies and single cell RNA-sequencing to examine the transcriptional and functional changes in fibroblasts in response to ischemia. RESULTS: Lineage tracing using Fsp1-Cre: R26R-EYFP mice revealed the emergence within the ischemic hindlimb of a small subset of YFP+ CD144+ CD11b- fibroblasts (E* cells) that expressed endothelial cell (EC) genes. Subcutaneous administration of Matrigel in Fsp1-Cre: R26R-EYFP mice generated a plug that became vascularized within 5 days. Isolation of YFP+ CD11b- cells from the plug revealed a small subset of YFP+ CD144+ CD11b- E* cells which expressed EC genes. Pharmacological or genetic suppression of innate immune signaling reduced vascularity of the Matrigel plug and abrogated the generation of these E* cells. These studies were repeated using human fibroblasts, with fluorescence-activated cell sorting analysis revealing that a small percentage of human fibroblasts that were induced to express EC markers in Matrigel plug assay. Pharmacological suppression or genetic knockout of inflammatory signaling abolished the generation of E* cells, impaired perfusion recovery and increased tissue injury after femoral artery ligation. To further characterize these E* cells, single cell RNA-sequencing studies were performed and revealed 8 discrete clusters of cells expressing characteristic fibroblast genes, of which 2 clusters (C5 and C8) also expressed some EC genes. Ischemia of the hindlimb induced expansion of clusters C5 and C8. The C8 cells did not express CD144, nor did they form networks in Matrigel, but did generate angiogenic cytokines. The C5 fibroblasts most resembled E* cells in their expression of CD144 and their ability to form EC-like networks in Matrigel. CONCLUSIONS: Together, these studies indicate the presence of subsets of tissue fibroblasts which seem poised to contribute to the angiogenic response. The expansion of these subsets with ischemia is dependent on activation of innate immune signaling and contributes to recovery of perfusion and preservation of ischemic tissue.
Authors: Masaki Ieda; Takatoshi Tsuchihashi; Kathryn N Ivey; Robert S Ross; Ting-Ting Hong; Robin M Shaw; Deepak Srivastava Journal: Dev Cell Date: 2009-02 Impact factor: 12.270
Authors: Jieun Lee; Nazish Sayed; Arwen Hunter; Kin Fai Au; Wing H Wong; Edward S Mocarski; Renee Reijo Pera; Eduard Yakubov; John P Cooke Journal: Cell Date: 2012-10-26 Impact factor: 41.582
Authors: Sandip Bhattacharyya; Christine K Ratajczak; Sherri K Vogt; Crystal Kelley; Marco Colonna; Robert D Schreiber; Louis J Muglia Journal: Blood Date: 2010-01-11 Impact factor: 22.113
Authors: Kunhua Song; Young-Jae Nam; Xiang Luo; Xiaoxia Qi; Wei Tan; Guo N Huang; Asha Acharya; Christopher L Smith; Michelle D Tallquist; Eric G Neilson; Joseph A Hill; Rhonda Bassel-Duby; Eric N Olson Journal: Nature Date: 2012-05-13 Impact factor: 49.962
Authors: Graeme M Birdsey; Aarti V Shah; Neil Dufton; Louise E Reynolds; Lourdes Osuna Almagro; Youwen Yang; Irene M Aspalter; Samia T Khan; Justin C Mason; Elisabetta Dejana; Berthold Göttgens; Kairbaan Hodivala-Dilke; Holger Gerhardt; Ralf H Adams; Anna M Randi Journal: Dev Cell Date: 2015-01-12 Impact factor: 12.270
Authors: Wuming Gong; Satyabrata Das; Javier E Sierra-Pagan; Erik Skie; Nikita Dsouza; Thijs A Larson; Mary G Garry; Edgar Luzete-Monteiro; Kenneth S Zaret; Daniel J Garry Journal: Nat Cell Biol Date: 2022-05-12 Impact factor: 28.213
Authors: Rulin Zhuang; Jingshu Chen; Henry S Cheng; Carmel Assa; Anurag Jamaiyar; Arvind K Pandey; Daniel Pérez-Cremades; Bofang Zhang; Aspasia Tzani; Akm Khyrul Wara; Jorge Plutzky; Victor Barrera; Preetida Bhetariya; Richard N Mitchell; Zhongmin Liu; Mark W Feinberg Journal: Circ Res Date: 2022-04-20 Impact factor: 23.213
Authors: Michael Graber; Felix Nägele; Jakob Hirsch; Leo Pölzl; Victor Schweiger; Sophia Lechner; Michael Grimm; John P Cooke; Can Gollmann-Tepeköylü; Johannes Holfeld Journal: Front Cardiovasc Med Date: 2022-05-12
Authors: Tom Alsaigh; Belinda A Di Bartolo; Jocelyne Mulangala; Gemma A Figtree; Nicholas J Leeper Journal: Circ Res Date: 2021-06-10 Impact factor: 23.213
Authors: Sarah E J Chambers; Varun Pathak; Edoardo Pedrini; Lou Soret; Nicolas Gendron; Coralie L Guerin; Alan W Stitt; David M Smadja; Reinhold J Medina Journal: Stem Cells Transl Med Date: 2021-11 Impact factor: 7.655